HighCom (HCL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
25 Apr, 2026Executive summary
Specialist in advanced ballistic protection and integrated drone solutions, serving defense, law enforcement, and first responders globally, with a focus on personnel protective systems and technology integration.
Structured into Armor (body armor, helmets, shields) and Technology (UAS, counter-UAS, integration, and training) divisions.
Revenue declined 59% year-over-year to $10.9m for H1 FY26, mainly due to the US government shutdown and tariff uncertainty impacting the Armor segment.
Strategic shift to US-produced products, refreshed management, and operational focus sharpened.
Strong customer relationships and positive market feedback, especially for new XTclave lightweight products.
Financial highlights
H1 FY26 revenue at $10.9 million, down from $26.6m year-over-year, with EBITDA loss of $5.4 million; net loss after tax was $6.8m.
Includes abnormal tax expense of $686,000 and currency impact of $232,000.
Technology division revenue stable year-over-year; Armor division heavily impacted by shutdown.
Gross profit: $1.3m (prior year: $6.8m); gross margin: 12% (prior year: 26%).
Cash at period end: $3.0m; inventory reduced to $12.5m from $14.4m at 30 June 2025.
Outlook and guidance
Expecting 100%-150% revenue uplift in H2 FY26 versus H1, aiming for break-even or slight profit.
Recovery in US government spending anticipated to normalize by Q4 H2 FY26.
Guidance dependent on timing of a large technology order, US government order recovery, and exchange rate fluctuations.
FY27 outlook strong, with pipeline and market activity supporting growth.
Opportunity pipeline for Armor exceeds US$55m for H2 FY26.
Latest events from HighCom
- Revenue fell 49% to $45.3m with a $12m net loss, but H2 EBITDA turned positive.HCL
H2 202426 Mar 2026 - Capital raise supports growth, XTclave® upgrades, and a return to profitability in H2 FY26.HCL
Investor presentation11 Feb 2026 - Achieved positive EBITDA and margin recovery, with new products set to drive FY26 growth.HCL
H2 202523 Nov 2025